BACKGROUND: Simultaneous inactivation of pig GGTA1 and CMAH genes eliminates carbohydrate xenoantigens recognized by human antibodies. The β4GalNT2 glycosyltransferase may also synthesize xenoantigens. To further characterize glycan-based species incompatibilities, we examined human and non-human primate antibody binding to cells derived from genetically modified pigs lacking these carbohydrate-modifying genes. METHODS: The Cas9 endonuclease and gRNA were…
Xenotransplantation Template
Write in a clean editor, then format for Xenotransplantation in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Xenotransplantation format
Xenotransplantation is a peer-reviewed journal published by Wiley, covering Xenotransplantation and immune response, Animal Genetics and Reproduction, Organ Transplantation Techniques and Outcomes.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Xenotransplantation 12 (3): 45–58.
Formats any DOI in Xenotransplantation style. No sign-up. |
| Publishes research in | Xenotransplantation and immune response Animal Genetics and Reproduction Organ Transplantation Techniques and Outcomes Tissue Engineering and Regenerative Medicine Pancreatic function and diabetes |
| ISSN | 0908-665X |
| Citation impact (2-yr) | 2.25 |
| h-index | 82 |
| i10-index | 1,011 |
| Total citations | 41,313 |
| Article processing charge | $4,120 |
| Top institutions publishing here | Massachusetts General Hospital |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Xenotransplantation per year
Citation impact of Xenotransplantation by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Xenotransplantation
BACKGROUND: The long-term viability and function of transplanted encapsulated neonatal porcine islets was examined in a diabetic patient. METHODS AND RESULTS: A 41-yr-old Caucasian male with type 1 diabetes for 18 yr was given an intraperitoneal transplant of alginate-encapsulated porcine islets at the dose of 15,000 islet equivalents (IEQs)/kg bodyweight (total dose 1,305,000 IEQs) via…
BACKGROUND: Clinical xenotransplantation is not possible because humans possess antibodies that recognize antigens on the surface of pig cells. Galα-1,3-Gal (Gal) and N-glycolylneuraminic acid (Neu5Gc) are two known xenoantigens. METHODS: We report the homozygous disruption of the α1, 3-galactosyltransferase (GGTA1) and the cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMAH) genes in liver-derived female pig cells using zinc-finger…
The first and major clinical obstacle in xenotransplantation is antibody-mediated hyperacute rejection. Although human natural antibodies against Galalpha1,3Gal (Gal) antigens, which are common on porcine cells and organs, have been identified to play a major role in hyperacute rejection, other natural antibodies against non-Gal epitopes may be also involved in the process. Here, we present…
BACKGROUND: Xenotransplantation using pig cells, tissues, or organs may be associated with the transmission of porcine microorganisms and the development of zoonoses. Among all porcine microorganisms porcine endogenous retroviruses (PERVs) represent a special risk because they are integrated in the genome of all pigs and able to infect human cells. In previous preclinical and retrospective…